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The amino acid L-arginine plays a crucial role in the regulation of immune responses. We
have recently shown that uncontrolled replication of Leishmania parasites at the site of
pathology correlates with high levels of arginase activity in nonhealing leishmaniasis and
that this elevated arginase activity causes local depletion of L-arginine. To further our
understanding of the impact of L-arginine deprivation in experimental leishmaniasis, here
we characterize in detail the effects of L-arginine deprivation on antigen-speciﬁc T cells
and MU. The results of our study show that decrease of L-arginine levels in the extra-
cellular milieu affects the biological activities of Leishmania major-speciﬁc T cells, both at
the level of the magnitude and the quality of their responses. L. major-speciﬁc CD4
1 T cells
rendered hyporesponsive by L-arginine deprivation can be partially rescued by addition of
exogenous L-arginine to produce IL-4 and IL-10, but not to produce IFN-c. Furthermore,
our results show that L-arginine deprivation also greatly impacts parasite growth in
activated macrophages. In summary, our results suggest that L-arginine levels affect both
Th cell responses and parasite replication.
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Introduction
The metabolism of the semi-essential amino acid L-arginine [1, 2]
by arginase is emerging as a crucial mechanism for the regulation
of immune responses. Arginase 1 is upregulated in myeloid cells
in response to a range of signals such as Th2 cytokines [3],
GM-CSF [4, 5], prostaglandin [6–8] and catecholamines [8].
Arginase 1 has been shown to affect T-cell responses by reducing
the availability of L-arginine: high arginase activity expressed by
myeloid cells results in increased uptake of extracellular
L-arginine into the cells, thereby reducing L-arginine levels in
the microenvironment; this decrease in L-arginine results in T-cell
hyporesponsiveness [9–13].
Experimental infection of mice with Leishmania major has
been extensively characterized as a model for host resistance or
susceptibility mediated by distinct Th subsets. The majority of
inbred strains of mice develop small lesions that heal sponta-
neously within a few weeks, leaving the host immune to re-
infection; this ability to control parasite replication correlates
with the expansion of CD4
1 Th1 cells, characterized by the
production of IFN-g. On the other hand, a few strains of mice
such as BALB/c develop progressive nonhealing disease, attrib-
uted to the expansion of CD4
1 Th2 cells, characterized by the
production of IL-4, IL-10 and IL-13 [14, 15].
Macrophages (MF), the main host cells for the intracellular
parasite Leishmania, are crucial for the outcome of disease:
depending on the expression of two inducible enzymes, NO
synthase 2 and arginase, MF can either kill the parasites or
promote their growth. These two enzymes share a common
substrate, L-arginine, and are competitively controlled by Th1 and
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oxidizes L-arginine into NO, a metabolite responsible for parasite
killing [17, 18]. In contrast, Th2 cytokines result in the induction
of arginase, which hydrolyzes L-arginine into ornithine, an amino
acid that is the main intracellular source for the synthesis of
polyamines; the latter are essential for parasite growth [19].
We have shown that uncontrolled replication of Leishmania
parasites at the site of pathology correlates with high levels of
arginase activity in nonhealing BALB/c mice, but not in healing
CBA mice [19]. This elevated arginase activity causes local
depletion of L-arginine (P. Kropf, unpublished data). Therefore,
in the present study we tested the effects of different levels of
L-arginine on Leishmania-speciﬁc T-cell responses and MF
effector functions.
Results
L-Arginine deprivation impairs antigen-speciﬁc T-cell
effector functions
We and others have shown that polyclonal stimulation of T cells
in the absence of L-arginine induces a profound T-cell hypo-
responsiveness [10, 12, 13, 20–23]; however, little is known
about the impact of L-arginine deprivation on antigen-speciﬁc
responses. Here, we assessed the impact of L-arginine starvation
on L. major-speciﬁc T-cell responses. To generate these cells,
healer (CBA) and nonhealer (BALB/c) mice were infected with
L. major parasites and 2wk post infection, cells from popliteal
lymph nodes were restimulated in vitro with L. major parasites
[24]. We ﬁrst measured the proliferation of CD4
1 T cells in
response to antigenic restimulation in the presence (400mM) or
in the absence (0mM) of L-arginine. The large majority (95.8%) of
CD4
1BrdU
1 T cells from nonhealer BALB/c mice are found in R2
(Fig. 1A, upper left panel); this represents 9.9% of all gated cells.
In contrast, in the absence of L-arginine, the percentage of
proliferating CD4
1 T cells is considerably lower (2.0%, Fig. 1A,
lower left panel). In addition, L-arginine deprivation also induces
a clear decrease in the frequency of proliferating CD4
1 T cells
(%CD4
1BrdU
1: 20.372.1% in the presence of L-arginine versus
2.170.3% in the absence of L-arginine, Fig. 1A). Similar results
were obtained with CD4
1 T cells from healer CBA mice
(11.070.8% in the presence of L-arginine versus 2.870.1% in
the absence of L-arginine, data not illustrated). A recent study has
described a new metric parameter, the integrated MFI (iMFI),
which reﬂects more precisely the total functional response of
activated T cells [25]. iMFI is calculated by multiplying the
percentage, which represents the magnitude of the response by
the MFI, which represents the quality of the response. As shown
in Fig. 1B, there is a remarkable decrease in iMFI of CD4
1BrdU
1
in the absence of L-arginine (BALB/c: 392.2732.6 versus
24.271.9, po0.05; CBA: 133.1711.8 versus 25.571.5,
po0.05), demonstrating that both the magnitude and the quality
of the proliferative response of antigen-speciﬁc CD4
1 T cells are
greatly impaired in the absence of L-arginine.
We also assessed how different concentrations of L-arginine
affect CD4
1 T-cell effector functions. We used culture media
containing 400, 100, 20 or 0mM L-arginine and measured the
proliferation of CD4
1 T cells from L. major-infected nonhealer
BALB/c and healer CBA mice. As shown in Fig. 1B, CD4
1 T cells
isolated from both healer and nonhealer mice proliferate less
efﬁciently in response to antigen in the media containing 100 and
20mM( po0.05), and the sharpest reduction in proliferation was
observed in the absence of L-arginine (0mM, po0.05).
To characterize further the impact of L-arginine deprivation
on CD4
1 T-cell effector functions, we assessed the ability of
L. major-speciﬁc CD4
1 T cells to produce IFN-g, IL-4 and IL-10 in
the absence of L-arginine. As shown in Fig. 2A and C, CD4
1
T cells from nonhealing BALB/c mice display a strong polarized
Th2-type response with high iMFI for CD4
1IL-4
1, but low iMFI
for CD4
1IFN-g
1; they also clearly produced the regulatory cyto-
kine IL-10; in contrast, the cytokine proﬁle of CD4
1 T cells from
Figure 1. L-Arginine deprivation impairs CD4
1 T-cell proliferation.
Individual popliteal lymph nodes were harvested from BALB/c and CBA
mice infected with L. major for 2wk (n54) and restimulated with L.
major parasites in the presence (400mM) or absence (0mM) of L-arginine.
After 5 days of in vitro restimulation, cells were harvested and the
percentage of proliferating CD4
1 T cells was determined as described
in the Materials and methods. (A) Dot plot proﬁles of CD4
1BrdU
1 T cells
(BALB/c mice); (B) iMFI of CD4
1 BrdU
1 T cells (BALB/c and CBA mice).
Data show mean7SD of four individual lymph nodes/group. Isotype
control: 0.59%. po0.05 as determined by a two-tailed Mann–Whitney
test. Data are representative of ﬁve independent experiments.
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lower iMFI for IL-4 and IL-10 (Fig. 2B and C). Importantly, when
cells from both groups of mice are restimulated with L. major
parasites in the absence of L-arginine, there is a statistically
signiﬁcant reduction in the iMFI of CD4
1IFN-g
1, CD4
1IL-4
1 and
CD4
1IL-10
1 (po0.05, Fig. 2A–C). Similar sharp reductions in
the levels of IFN-g, IL-4 and IL-10 were measured by Luminex in
supernatants of restimulated lymph node cells from BALB/c and
CBA mice (po0.05, Table 1, Supporting Information).
We also measured the effects of different concentrations of
L-arginine (400, 100, 20 or 0mM L-arginine) on the antigen-
speciﬁc cytokine production of CD4
1 T cells: the iMFI of CD4
1
IFNg
1 T cells (CBA mice) diminishes steadily with lower
concentration of L-arginine (Fig. 2C) and the iMFI for CD4
1IL-4
1
and CD4
1IL-10
1 T cells (BALB/c mice) remain unaltered at 400
and 100mM, and start to decrease with lower concentrations of
L-arginine (Fig. 2C).
L-Arginine deprivation did not induce increased cell death, as
both the total cell number per culture (Fig. 3, upper panel) and
the frequency of CD4
1 caspase
1 T cells (Fig. 3, lower panel) are
similar in both the presence and absence of L-arginine, suggesting
that cell death is not the cause for reduced T-cell activation and
function in the absence of L-arginine.
IL-4- and IL-10-producing CD4
1 T cells can be partially
rescued by addition of exogenous L-arginine
We have shown that stimulation of antigen-speciﬁc CD4
1 T cells
for 5 days in the absence of L-arginine results in severely impaired
proliferation and cytokine production (Figs. 1 and 2). To
determine whether CD4
1 T cells rendered hyporesponsive by
L-arginine deprivation could be rescued by addition of exogenous
L-arginine, we stimulated lymph node cells from L. major-infected
healer (CBA) and nonhealer (BALB/c) mice with L. major
parasites as antigen in the absence of L-arginine (0mM) and
added L-arginine (400mM) to the cultures after 1, 2, 3 or 4 days.
As controls, cells from both strains of infected mice were
restimulated with L. major parasites in the presence of L-arginine
(400mM) or in the absence of L-arginine (0mM) for 5 days; as
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Figure 2. Impaired capacity of antigen-speciﬁc CD4
1 T cells to express cytokines. Individual popliteal lymph nodes were harvested from BALB/c
and CBA mice infected with L. major for 2wk (n54) and restimulated with L. major parasites in the presence (400mM), absence (0mM) of L-arginine
(A and B) or at various concentrations of L-arginine (C). After 5 days of in vitro restimulation, cells were harvested and the percentage of cytokine-
producing CD4
1 T cells were determined as described in the Materials and methods. (A) Dot plot proﬁles of cytokine-producing CD4
1 T cells (BALB/c
mice; nonhealer). (B) Dot plot proﬁles of cytokine-producing CD4
1 T cells (CBA mice; healer). (C) iMFI of cytokine-producing CD4
1 T cells (BALB/c
and CBA mice). Data show mean7SD of four individual lymph nodes/group. Isotype control for IFN-g: 0.6370.1%, IL-4: 0.7870.12% and IL-10:
0.6770.10%. po0.05 as determined by a two-tailed Mann–Whitney test. Data are representative of ﬁve independent experiments.
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antigenic stimulation in the absence of L-arginine as compared
with those in the presence of L-arginine (Fig. 4A). When
exogenous L-arginine was added to the cells stimulated in the
absence of this amino acid, proliferation of antigen-speciﬁc CD4
1
T cells from both groups of mice could not be rescued, even when
added as soon as 1 day post stimulation. Similarly, complement-
ing the culture medium with 400mM L-arginine after 1 day
was not sufﬁcient to induce CD4
1 T cells to produce IFN-g
1
T cells (Fig. 4B). The inability to produce IFN-g could even not
be reversed by addition of L-arginine 3h post restimulation
(Fig. 4C). Th2 responses (BALB/c mice) could be partially
rescued by addition of exogenous L-arginine after 1 and 2 days
(Fig. 4B and C). Indeed, addition of L-arginine after 1 and 2 days
still results in production of IL-4 (43 and 29% of total response)
and IL-10 (49 and 21% of total response). To ensure that
the L-arginine used to supplement the L-arginine-free medium
was comparable to that of the commercially available
DMEM, L-arginine-free DMEM was used and supplemented
with 400mM L-arginine; lymph nodes cells were resuspended in
this medium, restimulated with L. major parasites and the
proliferation and cytokine production was compared with
those of cells restimulated in commercially available DMEM
(400mM). As presented in Table 2 (Supporting Information),
the proliferation and cytokine production was similar in both
conditions.
The results shown in Fig. 4B and C show that L. major-speciﬁc
CD4
1 T cells can be partially rescued to produce IL-4 and IL-10,
but cannot be rescued to produce IFN-g by addition of exogenous
L-arginine in vitro.
CD8
1 T cells play an important role in immunity to L. major
infection [26–29]. Therefore, we next assessed the impact of
L-arginine deprivation on L. major-speciﬁc CD8
1 T cells. Similar
to CD4
1 T cells, CD8
1 T cells from both groups of mice cannot
proliferate in the absence of L-arginine (data not illustrated). We
then measured their cytokine proﬁle and show that CD8
1 T cells
from healer CBA mice produced more IFN-g as compared with
nonhealer BALB/c mice (Fig. 5); no IL-4 or IL-10 was detectable
(data not illustrated). Similar to CD4
1 T cells, antigen-speciﬁc
CD8
1 T cells cannot produce IFN-g in response to antigenic
restimulation in the absence of L-arginine and cannot be rescued
by addition of exogenous L-arginine (Fig. 5, po0.05).
L-Arginine deprivation affects parasite growth in MU
It cannot be excluded that in the experiments described in
Figs. 1–5, antigen presentation is also altered by the absence of
L-arginine and therefore impacts on T-cell responses as well. It is
not possible to use co-culture experiments with L. major-infected
BMMF and T cells to dissect the impact of L-arginine deprivation
on these two cell types, as we already know that lack of L-arginine
results in impaired T-cell functions [10, 12, 13, 20–23]. There-
fore, here we tested how L-arginine deprivation impacts on
parasite growth and MF effector functions. L. major promasti-
gotes growth in cultures was not affected by the absence of
L-arginine: after 4 days in culture in the absence of L-arginine, the
number of viable parasite grown in the absence of L-arginine was
similar as that in the presence of L-arginine (21110
672210
6
versus 23410
671210
6, p40.05). Moreover, the viability of
the parasite did not seem to be critical as the use of L. major
antigen preparation to restimulate lymphoid cells from BALB/c
mice in the absence of L-arginine also resulted in a considerable
reduction of both the proliferation (Fig. 6A, left panel, po0.05)
and cytokine production (Fig. 6B, left panel, po0.05). Similar
results were obtained with cells from CBA mice (Fig. 6A, right
panel and Fig. 6C, po0.05).
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Figure 3. L-Arginine deprivation does not induce cell death. Individual
popliteal lymph nodes were harvested from BALB/c and CBA mice
infected with L. major for 2wk (n54) and restimulated with L. major
parasites in the presence (400mM) or absence (0mM) of L-arginine. After
5d a y so fin vitro restimulation, cells were harvested, live cells were
counted with Trypan blue staining (A) and the percentages of CD4
1
caspase3
1 cells (B) were determined by ﬂow cytometry. Data show
mean7SD. Data are representative of three independent experiments.
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phagocytose live L. major parasites was affected by the absence of
MF (Fig. 7B, po0.05); however, in the absence of L-arginine,
L. major parasites survived more efﬁciently than in the presence
of L-arginine (po0.05). Since parasite killing depends on the
production of NO resulting from the catabolism of L-arginine by
iNOS [17–19], we measured the production of NO by CAMF in
the presence or absence of L-arginine and as expected, there was
a drastic reduction in the production of NO in the absence of
L-arginine (Fig. 7C, po0.05).
To characterize the impact of L-arginine deprivation on MF
activation, we analyzed the expression levels of activation
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Figure 4. IL-4 and IL-10 production, but not IFN-g production can be partially rescued by addition of exogenous L-arginine. Individual popliteal
lymph nodes were harvested from BALB/c and CBA mice infected with L. major for 2wk (n54) and restimulated with L. major parasites in the
absence of L-arginine. (A and B) After 1, 2, 3 or 4 days, 400mM L-arginine was added to the cultures. In addition, some cells were restimulated with
L. major parasites in the presence (400mM, ‘‘0 day’’ group) or absence (0mM, ‘‘5 day’’ group) of L-arginine. After 5 days, cells were harvested and the
iMFI of CD4
1BrdU
1 cells (A) and the iMFI of cytokine-producing CD4
1 T cells (B) were determined as described in the Materials and methods. (C) After
3, 6 or 24h, L-arginine (400mM) was added to the cultures. In addition, some cells were restimulated continuously with L. major parasites in the
presence (400mM, ‘‘0 hour’’ group) of L-arginine. After 5 days, cells were harvested and the iMFI of cytokine-producing CD4
1 T cells were
determined as described in the Materials and methods. Data show mean7SD of CD4
1BrdU
1 iMFI or IFN-g
1,I L - 4
1 or IL-10
1 CD4
1 iMFI from four
individual lymph nodes/group. po0.05 as determined by a two-tailed Mann–Whitney test. Data are representative of three independent
experiments.
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of L-arginine during the differentiation of mature MF into CAMF
and AAMF did not signiﬁcantly affect the expression of CD206,
PDL1, MHCII and CD86 (p40.05). CD80 and CD69 were not
upregulated in any of the MF subsets tested (data not shown).
Since DC also play an important role in Leishmania infection, we
assessed the impact of L-arginine deprivation on the activation
of DC. Similar to BMMF, the expression levels of activation
markers on DC activated with either IL-4 or IFN-g and TNF-a
were not affected by the absence of L-arginine (Table 3,
Supporting Information). In the next step, we assessed whether
activated L. major-infected DC and MF require L-arginine
for the production of cytokines. Although no IL-10 or IL-12p70
were detectable under those conditions (data not shown),
the levels of IL-6 produced by DC derived from both BALB/c
and CBA mice in response to IFN-g and TNF-a were not affected
by L-arginine deprivation (p40.05, Table 4, Supporting
Information). Similarly, AAMF and CAMF derived from both
BALB/c and CBA mice produce similar levels of IL-6 (p40.05,
Fig. 7E).
The results shown in Fig. 7 suggest that although MF effector
functions tested here do not seem to be altered by L-arginine
deprivation, the growth of L. major parasites in MF is affected by
the absence of L-arginine.
Discussion
Using experimental infection of mice from healer and nonhealer
strains, we and others have previously shown that high arginase
activity is a hallmark of nonhealing leishmaniasis [19, 30, 31].
High enzymatic arginase activity requires high substrate turnover
and indeed, high arginase activity enhances L-arginine catabolism
in vivo resulting in signiﬁcantly reduced levels of L-arginine
(P. Kropf, unpublished data). In the present study, we character-
ized in detail the effects of L-arginine deprivation on the effector
functions of L. major-speciﬁc T cells isolated from healer and
nonhealer mice. The results of our study show that decrease
of L-arginine levels in the extracellular environment affect the
biological activities of L. major-speciﬁc T cells. These results are
mainly based on the evaluation of the total functional response of
antigen-speciﬁc T cells using a recently described metric
parameter, the iMFI [25]. Both the magnitude and quality of
the proliferative responses of antigen-speciﬁc T cells from
L. major-infected healer and nonhealer strains of mice are greatly
impaired by L-arginine starvation.
In agreement with the results of Rodriguez et al. [22], we
found here that increased cell death can be excluded as a cause
for the impaired proliferative response of antigen-speciﬁc T cells.
Our results suggest that cytokine production might be differen-
tially affected by variable L-arginine levels: IFN-g production by
T cells decline very rapidly to decreasing L-arginine levels
although IL-4- and IL-10-producing T cells maintained their
responsiveness longer and tolerated decreasing L-arginine levels
more efﬁciently. Of note, addition of exogenous L-arginine did
not restore impaired IFN-g production of hyporesponsive CD4
1
T cells; however, it partially rescued IL-4 and IL-10 production.
These results show that ﬂuctuations in L-arginine levels might
affect Th1 responses faster and more profoundly than Th2
responses. This differential responsiveness to decreasing L-argi-
nine levels may contribute to the different manifestations of
leishmaniasis, a disease requiring Th1-mediated immune
responses for parasite killing and healing.
L-Arginine is essential for the efﬁcient activation and function
of T cells; depletion of this amino acid in the extracellular
microenvironment by transport into myeloid cells in vivo –o r
modeled in vitro using L-arginine-free culture medium – induces
profound T-cell hyporesponsiveness, as shown by down-
regulation of proliferation, cytokine production and CD3z chain
expression [11–13, 21, 22, 32]. This T-cell dysfunction is directly
attributed to L-arginine deprivation that controls the cell cycle
and arrests the cells in the G0-G1 phase [33]. High arginase
expression has been associated with a variety of diseases
[12, 34–37]; however, a direct causal relationship between high
arginase activity, low L-arginine levels and T-cell hyporespon-
siveness has only been shown in a few conditions such as cancer
[38], tuberculosis [39] and pregnancy [13].
The effects of L-arginine depletion have been mainly
characterized using polyclonally stimulated T cells [11–13,
21–23, 32]; however, its effect on antigen-speciﬁc T cells has not
been analyzed in detail. Some studies have taken advantage of
OT-1 and OT-2 mice, which have one transgenic T-cell receptor
speciﬁc for an ovalbumin-immunodominant peptide; more than
90% of T cells express the transgene, providing a large pool of
T cells with one speciﬁcity. Stimulation of T cells from these mice
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Figure 5. Impaired capacity of antigen-speciﬁc CD8
1 T cells to express
IFN-g. Individual popliteal lymph nodes were harvested from BALB/c
and CBA mice infected with L. major for 2wk (n54) and restimulated
with L. major parasites in the absence of L-arginine. After 3, 6 or 24h,
L-arginine (400mM) was added to the cultures. In addition, some cells
were restimulated with L. major parasites in the presence (400mM, ‘‘0
hour’’ group) of L-arginine. After 5 days, cells were harvested and the
iMFI of cytokine-producing CD8
1 T cells were determined as described
in the Materials and methods. Data show mean7SD of IFN-g
1CD8
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from four individual lymph nodes/group. po0.05 as determined by a
two-tailed Mann–Whitney test. Data are representative of two inde-
pendent experiments.
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strongly impaired T-cell responses [40, 41].
We have recently shown that although L-arginine is uncondi-
tionally required for T-cell activation, MF can upregulate acti-
vation markers and produce cytokines and chemokines in the
absence of L-arginine; moreover, the absence of L-arginine did not
affect the capacity of activated MF to upregulate L-arginine-
metabolizing enzymes such as inducible NO synthase and argi-
nase 1 [23]. Here, we characterized the effects of L-arginine
deprivation on L. major-infected AAMF and CAMF and show that
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growth of L. major parasite was greatly impaired in AAMF, which
usually efﬁciently promote parasite growth [19, 42]. We have
previously shown that parasite replication depends on the
production of polyamines, which are derived from the catabolism
of L-arginine by arginase; therefore, in the absence of L-arginine,
the production of polyamine, and thereby the parasite growth,
will be greatly impaired [19]. Moreover, we also show here that
in the absence of L-arginine, parasites can replicate more efﬁ-
ciently in CAMF, because of the low NO production in the
absence of L-arginine. Although these experiments do not reveal
whether antigen presentation is altered in the absence of L-argi-
nine, these results show that L-arginine levels greatly affect
parasite growth in activated MF. Importantly, the levels of anti-
gen have been shown to determine the Th phenotype in experi-
mental leishmaniasis: low-dose infection are characterized by a
polarized Th1 response and healing and immunity to reinfection
[43, 44]. Therefore, it is tempting to speculate that high arginase
observed in nonhealing experimental leishmaniasis favors para-
site growth and thereby also promotes a strong polarized Th2
response.
In summary, we have shown that L-arginine depletion strongly
affects T-cell subsets induced by L. major infection. More detailed
studies of the mechanisms resulting in suppression of T-cell
responses by ﬂuctuating L-arginine levels and identiﬁcation of
mechanisms as to how to restore them are likely to lead to new
therapeutic or prophylactic means to treat not only leishmaniasis,
but also diseases such as asthma and cancer.
Materials and methods
Mice
Six- to eight-week-old female BALB/c and CBA mice (Charles
River, UK) were kept in individually vented cages. Animal
colonies, screened regularly for mouse pathogens, consistently
tested negative. Animal experiments were performed in accor-
dance with Home Ofﬁce and institutional guidelines.
Experimental infection with L. major parasites
For infections, 210
6 stationary phase L. major LV39 (MRHO/
SU/59/P-strain) promastigotes were injected s.c. into the foot-
pad [45].
Flow cytometric analyses
Popliteal lymph nodes from 2wk-infected BALB/c and CBA mice
were homogenized and 510
6/mL cells were activated with 110
6
live L. major parasites or 110
6 L. major antigen preparation
(L. major frozen and thawed three times) in DMEM (400mM
L-arginine), graded concentrations of L-arginine (100 and 20mM)
or L-arginine-free DMEM (0mM L-arginine), supplemented with 5%
FBS, 50IU/mL penicillin, 50mg/mL streptomycin and 292mg/mL
L-glutamine (Gibco). Cells were harvested after 5 days for further
analysis [24].
In the experiments where L-arginine was added to the cultures, a
stock solution of 100mM L-arginine (L-arginine-monohydrochlorid,
Roth) was prepared and 400mMw a sa d d e dt ot h ec u l t u r e s .
Proliferation assay
Before surface labeling with anti-CD4 mAb (clone H129.19
or GK1.5, Pharmingen) or anti-CD8 mAb (Clone 53–6.7,
eBioscience), cells were preincubated with 1mg of rat anti-mouse
mAb CD32/CD16 (FcgII/III receptor, Pharmingen). Cells were
washed, ﬁxed and permeabilized using the method described in
[29]. Detection of CD4
1BrdU
1 cells was performed using a
FACSCalibur (Becton Dickinson) and data were analyzed using
Summit v4.3 software.
Intracellular cytokine determination
Cells (110
6) were stimulated with 50ng of PMA (Sigma) and
500ng of ionomycin (Calbiochem) or, as a control, in the presence of
complete medium alone for 4h, with 10mgo fb r e f e l d i nA( S i g m a )
added for the last 2h. Before surface labeling with anti-CD4 mAb
(clone H129.19 or GK1.5, Pharmingen) or anti-CD8 mAb (Clone
53–6.7, eBioscience), cells were preincubated with 1mg of rat anti-
mouse mAb CD32/CD16 (FcgII/III receptor, Pharmingen). Cells were
w a s h e d ,ﬁ x e da n dp e r m e a b i l i z e da sd escribed in [24] before the anti-
cytokine antibodies or the isotype controls were added (anti-IL-4
mAb, clone BVD4-1D11; anti-IFN-g mAb, clone XMG1.2; anti-IL-10
mAb, clone JES5-16E3; appropriately labeled rat immunoglobulin
(Pharmingen)). Detection of intracellular cytokines was performed
using a FACSCalibur (Becton Dickinson) and data were analyzed
using Summit v4.3 software.
iMFI
The iMFI [25] was obtained by multiplying the percentage of
CD4
1 or CD8
1 T cells with the value of the MFI for BrdU or with
the value of the MFI for the relevant cytokine.
Activation markers
Anti-CD69, anti-MHCII, anti-CD86, anti-CD80, anti-CD69,
anti-PDL1 (eBioscience) and anti-CD206 (Serotec) were used
according to the supplier’s protocols. Detection of activation
markers was performed on a FACSCalibur (Becton Dickinson)
and data were analyzed using the Summit 4.0 software.
BMMU
BM was obtained by ﬂushing the femurs of BALB/c and CBA mice
and precursor cells were cultured in bacteria plates in DMEM
containing 10% heat-inactivated FBS, 5% horse serum and
the supernatant of L929 ﬁbroblasts at a ﬁnal concentration of
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a pure population of BM-derived MF. After 7 days in culture,
mature BMMF were harvested, activated for 2 days and infected
with L. major parasites at a ratio of 5:1 in the presence (400mM)
or in the absence (0mM) of L-arginine. To obtain CAMF, BMMF
were stimulated with 100U/ml IFN-g (PeproTech) and 500U/mL
TNF-a (PeproTech); to obtain alternatively activated MFAAMF,
BMMF were stimulated with 20U/ml IL-4 (PeproTech).
Phagocytosis assay
BMMF were seeded into 16-well glass slides (Lab-Tek, Nunc) at a
density of 710
4 BMMF per well and activated as described in the
section BMMF . Eighteen hours later, BMMF were infected at a
multiplicity of infection of 5 L. major promastigotes to 1 MF (MOI
5:1) in a 371C, 5% CO2 humidiﬁed incubator. Four hours later, the
MF were washed four times with PBS to remove non-phagocytosed
promastigotes. The slides were air dried, ﬁxed in methanol for 5min
and stained in 10%v/v Giemsa solution for 10min. The average
intracellular parasitemia was determined by oil-immersion micro-
scopy of at least 200 MF per treatment (performed in duplicate),
using the formula: (]parasites/]infected cells)  (]infected cells/
total ]cells)  100. Infections are expressed as the average number
of intracellular parasites per 100 infected MF.
Parasite growth
A total of 510
5 BMMF were activated as described above in a
ﬁnal volume of 1mL; 18h later, 2510
5 L. major parasite were
added to the cultures and 2 days later, the plates were washed
with PBS to remove non-phagocytosed promastigotes and the MF
were lysed as described in [45]. An aliquot of 100mL of this
suspension was added to 900mL of Schneider’s medium (Invitro-
gen, containing 10% FBS, 50IU/mL penicillin, 50mg/mL
streptomycin and 292mg/ml L-glutamine) and 6 days later, the
number of parasite per culture was counted.
DC
DC were generated as described in [3]. Brieﬂy, BM was obtained
by ﬂushing the femurs of BALB/c and CBA mice and precursor
cells were cultured in medium containing 5ng/mL GM-CSF for
10 days. DC were harvested, infected with L. major parasites at a
ratio of 5:1 and activated for two days with either a combination
of 100U/mL IFN-g (PeproTech) and 500U/mL TNF-a (Pepro-
Tech) or with 20U/mL IL-4 (PeproTech) in the presence
(400mM) or in the absence (0mM) of L-arginine.
Determination of arginase activity
Arginase activity was measured in MF lysates by the conversion
of L-arginine to urea as described in [3, 19]. One unit of enzyme
activity was deﬁned as the amount of enzyme that catalyzes the
formation of 1mmol of urea per min.
Nitrite determination
NO2
 accumulation was used as an indicator of NO production
and measured using Griess reagent [45].
Luminex
Lymphocytes, BMMF and DC were stimulated as described
above; supernatants were harvested and frozen until further use.
IFN-g, IL-4 and IL-10 (lymphocytes) or IL-12p70, IL-10 and IL-6
(BMMF) were detected simultaneously in each sample by the
Luminex-based Multiplexed assay (Luminex 100 System). Data
were analyzed using STarstation V2.0.
Statistical analyses
The reduction in responses observed between the results obtained
in the presence as compared with those obtained in the absence
of L-arginine were analyzed for statistical differences using a two-
tailed Mann–Whitney test and differences were considered
statistically signiﬁcant at po0.05.
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